DRREDDY.BO

Dr. Reddy's Laboratories Limited

HealthcareDrug Manufacturers - Specialty & GenericININRPeers →Country macro →

$1,328.35

+1.06%Jun 24, 2026

AI Brief

Market cap

$1.1T

52w range

—

P / E

—

EPS · FY 2026

$51.42

Volume

—

Revenue · FY 2026

$335.93B

Overview Fundamentals Valuation Market Ownership & flow Narrative & AI

Explain this page

Arphra AIPlain-English read on Dr. Reddy's Laboratories Limited’s valuation

AI Issuer Brief

Arphra AI

Loading cached brief…

Price

DB · prices_daily

1M 6M 1Y 5Y

Last

$1328.35

Change

-0.93%

Period high

$1354.75

Period low

$1155.50

Period start

$1340.852025-06-25

Through 2026-06-24

Fair value

Football field →

Weighted blend

$1,116.74

— vs spot

Recommendation

n/a

3 of 3 methods

Method spread

0bull0bear

±5% threshold

Candlestick · 1Y

Open in chart workstation →

DRREDDY.BO

1,328-0.93%

H 1,376L 1,149MA50 1,288MA200 1,265Avg vol 101K

Insider · 30d

History →

Bought

0 txns

Sold

0 txns

Net flow

+$0

Recent quarters

All financials →

Period	Revenue	Net income	EPS

Sector & industry today

Live

Sectors

Real Estate
+1.26%
Utilities
+0.96%
Consumer Cyclical
+0.94%
Energy
+0.84%
Financial Services
+0.65%
Basic Materials
-0.11%
Communication Services
-0.40%
Healthcare
-0.41%
Industrials
-0.47%
Technology
-0.80%
Consumer Defensive
-1.00%

Top industries (issuer's industry highlighted)

Drug Manufacturers - Specialty & Generic
+0.88%
Biotechnology
+6.56%
Financial - Mortgages
-4.05%
Home Improvement
+3.89%
Electrical Equipment & Parts
+3.88%
Paper, Lumber & Forest Products
+3.53%
Software - Services
-3.30%
Software - Infrastructure
-3.07%
Financial - Conglomerates
+2.62%
Auto - Dealerships
+2.54%
Luxury Goods
+2.47%
Auto - Recreational Vehicles
+2.22%

Analyst view

Consensus target

—

No price-target data returned for this ticker.

Recent actions

0 ↑0 ↓0 hold

No recent grade actions.

News

DB · news_items

No recent news for DRREDDY.BO.

Peers

No peer list available for DRREDDY.BO.

Total assets

$579.35B

Total debt

$89.54B

Cash & equiv

$15.37B

Operating CF

$53.84B

Free cash flow

$30.51B

Buybacks

Recent insiders

All →

Insider	Action	Shares	Value	Date
No open-market insider activity in the recent window.

Income statement · annual

Open Financials →

Period	Revenue	Op income	Net income	EPS	Net margin
FY 2026	$335.93B	$46.44B	$42.85B	$51.42	+12.76%